IRVINE, Calif., Feb. 7, 2018 /PRNewswire/ — Evolus, Inc. (“Evolus”), a medical aesthetics company focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments, today announced the pricing of its initial public offering of 5,000,000…
